Thyroid Eye Disease- @Teprotumumab- trbw- ( Tepezza)- (Jan 2020)

Drug Name:
Thyroid Eye Disease- @Teprotumumab- trbw- ( Tepezza)- (Jan 2020)

List Of Brands:

Indication Type Description:

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation

   

Indication:

U.S. FDA APPROVED  DRUGS DURING 2020

Sr.No-  2

Name of the  Drug-      TEPEZZA
 
Active Ingredient -       Teprotumumab-trbw
 
Pharmacological Classification- 
 
                                       To treat Thyroid eye disease
 
                                                                                                                                        Date of Approval-          1/21/2020
 
(Ref- FDA approved List 2020)

 

 

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the information needed to use                                 TEPEZZA safely and effectively.

See full prescribing information for TEPEZZA. TEPEZZA (teprotumumab-trbw) for injection, for intravenous use

 

Initial U.S. Approval: 2020

 

INDICATIONS AND USAGE

­ TEPEZZA is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of Thyroid Eye Disease